Metraipolis › archive › dc_fb6dd2009a33
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42338005
- DOI
- 10.1002/ijc.70584
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T05:39:32.125Z
- SHA-256 of the archived text
3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36- Stable URL of this page
https://metraipolis.com/documento/dc_fb6dd2009a33
How to cite
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005 — Europe PMC (en), https://europepmc.org/article/MED/42338005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb6dd2009a33 (Metraipolis archive dc_fb6dd2009a33, sha256 3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36)
BibTeX
@misc{dcfb6dd2009a33,
title = {A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42338005},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb6dd2009a33; sha256 3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338005. Agents can read the archived copy with the MCP tool read_document.